641 related articles for article (PubMed ID: 832632)
1. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
Ruh TS; Baudendistel LJ
Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of antiestrogen action: temporal patterns of antagonism of estrogen stimulated uterine growth and effects on estrogen receptor levels.
Ferguson ER; Katzenellenbogen BS
Endocrinology; 1977 May; 100(5):1242-51. PubMed ID: 849721
[TBL] [Abstract][Full Text] [Related]
3. Antiestrogen action in the uterus: biological ineffectiveness of nuclear bound estradiol after antiestrogen.
Katzenellenbogen BS; Ferguson ER
Endocrinology; 1975 Jul; 97(1):1-12. PubMed ID: 166821
[TBL] [Abstract][Full Text] [Related]
4. Control of uterine estrogen receptor levels by progesterone.
Hsueh AJ; Peck EJ; Clark JH
Endocrinology; 1976 Feb; 98(2):438-44. PubMed ID: 174899
[TBL] [Abstract][Full Text] [Related]
5. Effects of nafoxidine on the luteinizing hormone surge: temporal distribution of estrogen receptors and induction of cytoplasmic progestin receptors in the hypothalamus-preoptic area, pituitary, and uterus of the immature rat.
Attardi B; Palumbo LA
Endocrinology; 1981 Nov; 109(5):1365-74. PubMed ID: 7297482
[TBL] [Abstract][Full Text] [Related]
6. Diethylstilbestrol metabolites and analogs: differential ligand effects on estrogen receptor interactions with nuclear matrix sites.
Metzger DA; Curtis S; Korach KS
Endocrinology; 1991 Apr; 128(4):1785-91. PubMed ID: 2004602
[TBL] [Abstract][Full Text] [Related]
7. The effect of low dose continuous exposure to estradiol on the estrogen receptor (type I) and nuclear type II sites.
Markaverich BM; Roberts RR; Alejandro M; Clark JH
Endocrinology; 1984 Mar; 114(3):814-20. PubMed ID: 6697964
[TBL] [Abstract][Full Text] [Related]
8. Antiestrogen action: differential nuclear retention and extractability of the estrogen receptor.
Baudendistel LJ; Ruh TS
Steroids; 1976 Aug; 28(2):223-37. PubMed ID: 973236
[TBL] [Abstract][Full Text] [Related]
9. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen.
Dix CJ; Jordan VC
Endocrinology; 1980 Dec; 107(6):2011-20. PubMed ID: 7191796
[TBL] [Abstract][Full Text] [Related]
10. Continuous estrogen exposure in the rat does not induce loss of uterine estrogen receptor.
Jakesz R; Kasid A; Lippman ME
J Biol Chem; 1983 Oct; 258(19):11798-806. PubMed ID: 6619144
[TBL] [Abstract][Full Text] [Related]
11. Actions and interactions of delta 5-androstene-3 beta, 17 beta-diol and 17 beta-estradiol in the immature rat uterus.
van Doorn LG; Poortman J; Thijssen JH; Schwarz F
Endocrinology; 1981 Apr; 108(4):1587-93. PubMed ID: 7472285
[TBL] [Abstract][Full Text] [Related]
12. Progesterone action in hamster uterus: rapid inhibition of 3H-estradiol retention by the nuclear fraction.
Evans RW; Leavitt WW
Endocrinology; 1980 Oct; 107(4):1261-3. PubMed ID: 7408773
[TBL] [Abstract][Full Text] [Related]
13. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
Clark JH; Markaverich B; Upchurch S; Eriksson H; Hardin JW
Adv Exp Med Biol; 1979; 117():17-46. PubMed ID: 474276
[TBL] [Abstract][Full Text] [Related]
14. Selective blockade of estrogen-induced uterine responses by the antiestrogen nafoxidine.
Gardner RM; Kirkland JL; Stancel GM
Endocrinology; 1978 Nov; 103(5):1583-9. PubMed ID: 748005
[TBL] [Abstract][Full Text] [Related]
15. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
Pavlik EJ; Nelson K; Srinivasan S; Powell DE; Kenady DE; DePriest PD; Gallion HH; van Nagell JR
Cancer Res; 1992 Aug; 52(15):4106-12. PubMed ID: 1638522
[TBL] [Abstract][Full Text] [Related]
16. The testicular estrogen receptor system in two strains of mice differing in susceptibility to estrogen-induced Leydig cell tumors.
Sato B; Spomer W; Huseby RA; Samuels LT
Endocrinology; 1979 Mar; 104(3):822-31. PubMed ID: 436739
[TBL] [Abstract][Full Text] [Related]
17. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a unique population of unfilled estrogen-binding sites associated with the nuclear fraction of immature rat uteri.
Carlson RA; Gorski J
Endocrinology; 1980 Jun; 106(6):1776-85. PubMed ID: 7371593
[TBL] [Abstract][Full Text] [Related]
19. Stimulatory and inhibitory effects of estrogen on uterine DNA synthesis.
Stormshak F; Leake R; Wertz N; Gorski J
Endocrinology; 1976 Dec; 99(6):1501-11. PubMed ID: 1001250
[TBL] [Abstract][Full Text] [Related]
20. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
Lippman M; Bolan G; Huff K
Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
